Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Evaluation of the Lungs of Individuals With Lung Disease
A completed clinical trial evaluating lung function in individuals with various lung diseases including bronchitis, emphysema, COPD, and ast…
-
CLINICAL_TRIALS research · 2016-05-02Clinical Trial Update: Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
A completed clinical trial update describing a genetic blood collection study from individuals with lung diseases in Qatar.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
This completed clinical trial investigates how exposure to cigarette smoke modulates genes that regulate cilia length in individuals with ch…
-
FDA approval · 2016-04-29FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for ATROVENT HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval …
-
FDA approval · 2016-04-29FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, expanding…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-29FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline LLC.
-
EMA guidance · 2016-04-29EMA completes review of inhaled corticosteroids for chronic obstructive pulmonary disease
The EMA completes its review of inhaled corticosteroids for chronic obstructive pulmonary disease, summarizing regulatory assessment and any…
-
CLINICAL_TRIALS research · 2016-04-29Clinical Trial Update: Blood Collection From Individuals With Lung Disease for Genetic Studies
A completed clinical trial update describing blood collection from people with lung diseases for genetic studies to advance understanding of…
-
CLINICAL_TRIALS research · 2016-04-29Clinical Trial Update: Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease [NA]
An update on a clinical trial evaluating osteopathic techniques for residual volume in severe chronic obstructive pulmonary disease; the stu…
-
FDA approval · 2016-04-28FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory, LLC.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Airway Inflammation and Remodeling in Asthma and COPD.
This document provides an update on a completed clinical trial studying airway inflammation and remodeling in asthma and chronic obstructive…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State [Phase 4]
Phase 4 trial evaluating the benefit of at-home nebulized bronchodilators in patients with severe chronic obstructive pulmonary disease has …
-
FDA approval · 2016-04-25FDA Approved: BEVESPI AEROSPHERE — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Bevespi Aerosphere, a fixed-dose inhalation combination of glycopyrrolate and formoterol fumarate, under its original applicati…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Effects of Symbicort on the Ventilatory Kinematics [Phase 4]
A Phase 4 trial assessing Symbicort's effects on ventilatory kinematics in chronic obstructive pulmonary disease has been terminated, with r…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD [Phase 2]
Phase 2 trial evaluating whether the Aridol inhalation challenge can predict which COPD patients will respond to inhaled corticosteroids.
-
FDA approval · 2016-04-15FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) by Boehringer Ingelheim Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD [Phase 4]
Phase 4 trial assessing the effect of glycopyrronium on morning COPD symptoms and pulmonary function; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Microbiology & Immunology of the Chronically-inflamed Airway
A completed clinical trial update from University Hospital Southampton NHS Foundation Trust focusing on the microbiology and immunology of c…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Lung Health Study (LHS) I and III [Phase 3]
The Lung Health Study I and III Phase 3 trial sponsored by NHLBI has completed. The update indicates the study concerns lung diseases, speci…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: National Emphysema Treatment Trial (NETT) [Phase 3]
Clinical trial update for the National Emphysema Treatment Trial (NETT) indicates the Phase 3 study has completed. The trial concerns emphys…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Feasibility of Inspiratory Muscle Training in People With COPD Who Decline Pulmonary Rehabilitation [NA]
This clinical trial update reports on the feasibility of inspiratory muscle training in people with chronic obstructive pulmonary disease wh…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Clinical Study of Intermittent Positive Pressure Breathing (IPPB) [Phase 3]
A Phase 3 clinical trial evaluating intermittent positive pressure breathing (IPPB) for lung diseases has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing fluticasone furoate/vilanterol inhalation powder to vilanterol alone in COPD; study completed with posted results in…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Clinical Study to Investigate Safety and Performance of NeuRx DPS in Patients Undergoing Bilateral Lung Transplantation [NA]
This clinical trial update reports completion of a study evaluating the safety and performance of the NeuRx DPS diaphragmatic pacing system …
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease
This clinical trial update describes a prospective cohort study using hyperpolarized helium-3 MRI to assess chronic obstructive pulmonary di…